Birchview Capital, LP - IMPRIMIS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201.

Links
Filings
External links
Quarter-by-quarter ownership
Birchview Capital, LP ownership history of IMPRIMIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,024,000
+104.8%
180,0000.0%0.97%
+200.0%
Q3 2018$500,000
+26.3%
180,0000.0%0.32%
+20.1%
Q2 2018$396,000–180,000–0.27%–
 Download
Other shareholders

There were no reported owners of IMPRIMIS PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMPRIMIS PHARMACEUTICALS INC shareholders